. Author manuscript; available in PMC: 2022 May 16.

Published in final edited form as: Mol Cancer Ther. 2018 Sep 17;17(12):2610–2621. doi: 10.1158/1535-7163.MCT-17-0541

Table 1.

The combination index calculated by CalcuSyn software

Sorafenib (μM)	Carfilzomib (nM)	Hep3B		Bel-7402
Sorafenib (μM)	Carfilzomib (nM)	Fa	CI	Fa	CI
1.25	12.5	0.162	1.589	0.187	1.091
2.5	25	0.368	0.757	0.315	0.895
5.0	50	0.575	0.506	0.494	0.692
7.5	100	0.651	0.591	0.620	0.632